{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:55:21Z","timestamp":1766134521874,"version":"3.48.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["SRG2023\\u201300062-ICI"],"award-info":[{"award-number":["SRG2023\\u201300062-ICI"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["MYRG-GRG2024\\u201300071-IC"],"award-info":[{"award-number":["MYRG-GRG2024\\u201300071-IC"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009409","name":"Russian Science Support Foundation","doi-asserted-by":"publisher","award":["21\\u201315-00212"],"award-info":[{"award-number":["21\\u201315-00212"]}],"id":[{"id":"10.13039\/100009409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.pnpbp.2025.111569","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:32:25Z","timestamp":1764894745000},"page":"111569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NMDA glutamate receptor polymorphisms modulate antipsychotic-induced hyperprolactinemia in schizophrenia"],"prefix":"10.1016","volume":"143","author":[{"given":"Olga Yu.","family":"Fedorenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeniya G.","family":"Poltavskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena G.","family":"Kornetova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxim B.","family":"Freidin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna V.","family":"Bocharova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasiya S.","family":"Boiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim A.","family":"Stepanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolay A.","family":"Bokhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana A.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuzma","family":"Strelnikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2025.111569_bb0005","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3390\/biom10060947","article-title":"Brain NMDA receptors in schizophrenia and depression","volume":"10","author":"Adell","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/eje.0.1370099","article-title":"Interactions between N-methyl-D-aspartate, nitric oxide and serotonin in the control of prolactin secretion in prepubertal male rats","volume":"137","author":"Aguilar","year":"1997","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41574-019-0194-6","article-title":"Prolactin - a pleiotropic factor in health and disease","volume":"15","author":"Bernard","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11920-023-01460-6","article-title":"Evidence-based recommendations for the pharmacological treatment of women with schizophrenia Spectrum disorders","volume":"25","author":"Brand","year":"2023","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1017\/S0033291721004591","article-title":"Antipsychotic medication for women with schizophrenia spectrum disorders","volume":"52","author":"Brand","year":"2022","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0035","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1055\/s-2006-931483","article-title":"The neurochemical circuitry of schizophrenia","volume":"39","author":"Carlsson","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0040","first-page":"25","article-title":"Hyperprolactinemia and EYP2D8, DTD2, JVT2E gene polymorphism in patients with schizophrenia","volume":"21","author":"Fedorenko","year":"2017","journal-title":"Physiol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0045","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3390\/diagnostics12071521","article-title":"Genes of the glutamatergic system and tardive dyskinesia in patients with schizophrenia","volume":"12","author":"Fedorenko","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0050","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/bcp.14288","article-title":"Association between 8 P-glycoprotein (MDR1\/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia","volume":"86","author":"Geers","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0055","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1210\/endo.140.3.6568","article-title":"Regulation of growth hormone secretion by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in infantile, prepubertal, and adult male rats","volume":"140","author":"Gonzalez","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1677\/joe.0.1620417","article-title":"Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats","volume":"162","author":"Gonzalez","year":"1999","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0065","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1677\/joe.0.1660669","article-title":"Regulation of prolactin secretion by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in male rats","volume":"166","author":"Gonzalez","year":"2000","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109941","article-title":"Antipsychotic-induced hyperprolactinemia in aging populations: prevalence, implications, prevention and management","volume":"101","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neulet.2016.07.038","article-title":"A study of single nucleotide polymorphisms of GRIN2B in schizophrenia from Chinese Han population","volume":"630","author":"Guo","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0080","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1085\/jgp.201812032","article-title":"Structure, function, and allosteric modulation of NMDA receptors","volume":"150","author":"Hansen","year":"2018","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0085","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1038\/s41380-023-02265-y","article-title":"GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia","volume":"28","author":"Harrison","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0090","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/jpm11121250","article-title":"Evidence for the association between the intronic haplotypes of ionotropic glutamate receptors and first-episode schizophrenia","volume":"11","author":"Hirschfeldova","year":"2021","journal-title":"J Personal. Med."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jphs.2016.10.002","article-title":"Human GRIN2B variants in neurodevelopmental disorders","volume":"132","author":"Hu","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0100","first-page":"6461907","article-title":"Levodopa-induced dyskinesia is related to indirect pathway medium spiny neuron excitotoxicity: a hypothesis based on an unexpected finding","volume":"2016","author":"Ivanova","year":"2016","journal-title":"Parkinson\u2019s Disease"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2011.66","article-title":"NMDA receptor genotypes associated with the vulnerability to develop dyskinesia","volume":"2","author":"Ivanova","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0110","doi-asserted-by":"crossref","DOI":"10.1177\/2050312116643673","article-title":"Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: a comparison of genetic variants in two independent patient populations","volume":"4","author":"Ivanova","year":"2016","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2016.10.029","article-title":"Prolactin gene polymorphism (\u22121149 G\/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics","volume":"182","author":"Ivanova","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/15622975.2016.1224926","article-title":"Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia","volume":"18","author":"Ivanova","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ajp.20357","article-title":"Neuroendocrine regulation of prolactin secretion in adult female rhesus monkeys during different phases of the menstrual cycle: role of neuroexcitatory amino acid (NMA)","volume":"69","author":"Jahan","year":"2007","journal-title":"Am. J. Primatol."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0130","first-page":"153","article-title":"Clinical presentations of drug-induced Hyperprolactinaemia: a literature review","volume":"37","author":"Junqueira","year":"2023","journal-title":"Pharmaceut. Med."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.schres.2020.04.031","article-title":"Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: a systematic review and meta-analysis","volume":"222","author":"Labad","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41398-021-01471-y","article-title":"Genome wide study of tardive dyskinesia in schizophrenia","volume":"11","author":"Lim","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0150","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/0024-3205(90)90158-N","article-title":"Direct stimulation of pituitary prolactin release by glutamate","volume":"47","author":"Login","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41398-022-02027-4","article-title":"Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis","volume":"12","author":"Lu","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2021.100913","article-title":"Decoding signaling pathways involved in prolactin-induced neuroprotection: a review","volume":"61","author":"Molina-Salinas","year":"2021","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2016.09.037","article-title":"Phenotypes associated with psychiatric disorders are sex-specific in a mutant mouse line","volume":"1652","author":"Nakajima","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0170","first-page":"421","article-title":"The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review","volume":"28","author":"Peuskens","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0175","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1523\/JNEUROSCI.21-11-04104.2001","article-title":"NMDA-mediated activation of the medial amygdala initiates a downstream neuroendocrine memory responsible for pseudopregnancy in the female rat","volume":"21","author":"Polston","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0180","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3390\/life11100997","article-title":"Study of early onset schizophrenia: associations of GRIN2A and GRIN2B polymorphisms","volume":"11","author":"Poltavskaya","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0185","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/genes14030575","article-title":"The role of glutamatergic gene polymorphisms in the clinical phenotypes of schizophrenia","volume":"14","author":"Poltavskaya","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/ijms25010110","article-title":"Current review of the function and regulation of Tuberoinfundibular dopamine neurons","volume":"25","author":"Qi-Lytle","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0195","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/bcp.12312","article-title":"Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms","volume":"77","author":"Reynolds","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176910","article-title":"Prolactin-induced neuroprotection against glutamate excitotoxicity is mediated by the reduction of [Ca2+]i overload and NF-kappaB activation","volume":"12","author":"Rivero-Segura","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2019.02.027","article-title":"Prolactin prevents mitochondrial dysfunction induced by glutamate excitotoxicity in hippocampal neurons","volume":"701","author":"Rivero-Segura","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0210","article-title":"Antipsychotics-induced hyperprolactinemia and screening for macroprolactin","volume":"31","author":"Ruljancic","year":"2021","journal-title":"Biochemia Medica (Zagreb)"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0215","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/brain\/awy304","article-title":"GRIN2A-related disorders: genotype and functional consequence predict phenotype","volume":"142","author":"Strehlow","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2025.111569_bb0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2007.11.033","article-title":"World psychiatric association Pharmacopsychiatry section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia","volume":"100","author":"Tandon","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2025.111569_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148129","article-title":"MPX-004 and MPX-007: new pharmacological tools to study the physiology of NMDA receptors containing the GluN2A subunit","volume":"11","author":"Volkmann","year":"2016","journal-title":"PLoS One"},{"year":"2004","series-title":"International Statistical Classification of Diseases and Health Related Problems ICD-10","author":"WHO","key":"10.1016\/j.pnpbp.2025.111569_bb0230"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625003239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625003239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:53:00Z","timestamp":1766134380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625003239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":46,"alternative-id":["S0278584625003239"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111569","relation":{},"ISSN":["0278-5846"],"issn-type":[{"type":"print","value":"0278-5846"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NMDA glutamate receptor polymorphisms modulate antipsychotic-induced hyperprolactinemia in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111569"}}